Peter J. Houghton

Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin

Gregory J. Brunn, Christine C. Hudson, Aleksandar Sekulić et al. · Science · 1997 · 957 citations

A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity

Sajid Khan, Xuan Zhang, Dongwen Lv et al. · Nature Medicine · 2019 · 608 citations · Full text

Oncology, Medicine, Potent Antitumor Activity +7

The pediatric preclinical testing program: Description of models and early testing results

Peter J. Houghton, Christopher L. Morton, Chandra L. Tucker et al. · Pediatric Blood & Cancer · 2006 · 482 citations

Establishment of human tumor xenografts in immunodeficient mice

Christopher L. Morton, Peter J. Houghton · Nature Protocols · 2007 · 482 citations · Full text

Xenotransplantation, Oncogenic Agent, Medicine +4

In-vitro Inhibition of Human Erythrocyte Acetylcholinesterase by <i>Salvia lavandulaefolia</i> Essential Oil and Constituent Terpenes

Nicolette S L Perry, Peter J. Houghton, A.E. Theobald et al. · Journal of Pharmacy and Pharmacology · 2000 · 445 citations · Full text